AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

LEXINGTON, Mass.–(BUSINESS WIRE)–Feb. 13, 2012–
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that
management will provide a brief overview of the company followed by a
question and answer period with investors at the following investor
conferences during the month of February:

• February 16, at 9:30 a.m. ET – Leerink Swann 2012 Global Healthcare
  Conference in New York City; and
• February 27, at 11:30 a.m. ET – Citi 2012 Global Healthcare Conference
  in New York City.

A live webcast of each presentation will be accessible through the
Investors section of the company’s website at www.amagpharma.com.
Following the conference, the webcast will be archived on the AMAG
Pharmaceuticals, Inc. website for approximately two weeks.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
development and commercialization of a therapeutic iron compound to
treat iron deficiency anemia. For additional company information, please
visit www.amagpharma.com.

Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303